MBO Finance: Funding a Management Buyout

There is rarely one source. A typical structure layers several of the following:

• Senior bank or asset-based debt - the cheapest layer, secured against the company's assets and cash flow, usually the first piece arranged.
• Private credit / unitranche - a single blended facility from a direct lender, often used where a bank alone cannot stretch far enough or speed matters more than the lowest coupon.
• Mezzanine or junior debt - subordinated to the senior lender, more expensive, and used to close a gap without diluting management further. See our mezzanine finance guide for how this layer is priced and structured on its own.
• Vendor loan note - the seller defers part of the price and gets paid over time, ranking behind senior debt. Often the cheapest way to bridge value and debt capacity, but the seller carries post-completion credit risk.
• Management equity - meaningful relative to each manager's personal means, but rarely enough on its own to close a material gap.
• Private equity - fills whatever is left after debt, vendor deferral and management cash, in exchange for dilution, governance rights and an exit timetable.
• Invoice finance or ABL - where the business is asset-rich but EBITDA is thin, receivables and stock can sometimes raise more capacity than a pure cash-flow loan. See invoice finance for advance rates and mechanics.

A worked example

Take a business with £2.0m of normalised EBITDA sold at 5.5x, giving an £11.0m enterprise value, plus £0.6m of fees and minimum liquidity required at completion. £11.6m total needs funding.

Uses	£m	Sources	£m
Enterprise value paid	11.0	Senior bank debt at 2.25x EBITDA	4.5
Fees and minimum liquidity	0.6	Vendor loan note	2.0
		Management equity	0.4
		PE sponsor equity	4.7
Total	11.6	Total	11.6

Debt funds only 41% of the total. The seller carries 17% through the vendor note. Management and the PE sponsor fund the remaining 42% between them. This is roughly the shape of proportions in a mid-sized, PE-backed UK MBO: senior debt covers less than half, and the rest is a negotiation between seller patience, management commitment and sponsor equity.

There is no statutory minimum management investment. Banks and private-equity investors expect an amount that is meaningful relative to each manager's personal means, not a fixed percentage of the deal. The funding model should never assume management cash can bridge the main purchase-price gap between valuation and debt capacity; that is what vendor deferral, mezzanine and sponsor equity are for. Where private equity backs the deal, management typically holds a minority "sweet equity" stake alongside good-leaver and bad-leaver provisions, vesting, and drag-along and tag-along rights, all of which need agreeing before completion, not after.

One tax point catches teams out routinely: shares acquired by managers because of their employment are employment-related securities, and if acquired below market value the discount can be taxed as employment income. Restricted shares commonly need a joint section 431 ITEPA 2003 election within 14 days of acquisition, so future growth in value is not taxed as restrictions lift. Missing that 14-day window creates avoidable tax exposure that cannot easily be fixed later.

Provider fit changes sharply with EBITDA. Below £1m EBITDA, institutional private equity has limited appetite and financing usually comes from specialist banks, regional lenders, asset-based lending, vendor finance and management cash. Between £1m and £3m, regional PE, family offices, sponsorless private debt and challenger banks such as Shawbrook and OakNorth become active; Shawbrook publishes £3m-£25m corporate leverage loans and £5m-£50m ABL facilities. From £3m to £10m EBITDA, competition broadens across lower-mid-market private equity (YFM Equity Partners, Maven Capital Partners, Connection Capital) and private debt (Beechbrook Capital, ThinCats), alongside senior bank facilities. Above £10m, national and international mid-market houses such as LDC, Inflexion and Equistone compete for majority or significant-minority buyouts, typically investing £10m-£75m and up. BGF sits slightly apart, providing minority growth and succession capital from £3m-£30m without taking control, which can suit an MBO alongside other sources rather than as the sole funder.

For the seller, an MBO trades some price certainty for confidentiality, continuity and speed. There is usually no auction process and no strategic buyer paying for synergies the incumbent team cannot offer, so a friendly or vendor-initiated MBO can close below a fully marketed trade-sale price. What it buys back is control over information reaching competitors and staff, continuity for customers and employees the seller has worked with for years, and a shorter, less adversarial process than a wide sale. Where a seller is willing to take deferred consideration and values a clean handover over the last few percentage points of price, that trade-off often makes sense.

For the management team, an MBO is rarely about buying cheap. It is about controlling their own future rather than working for whoever the seller sells to next, often a strategic acquirer or a PE house with its own plans for the business. A strong, well-financed management team backed by private equity can still pay full market value where lender capacity and competition support it; the discount, where one exists, comes from the absence of an auction, not from management getting a bargain by definition.